DXC Technology shares jumped 7.5% in pre-open trading after the company disclosed a multi-year global alliance with Anthropic, the developer of the Claude family of AI models. Under the agreement, DXC will integrate Claude directly into the mission-critical enterprise systems it operates for major corporate and government clients.
As part of the partnership, DXC will join the Claude Partner Network as one of a limited set of Global Premier partners. The collaboration includes the creation of a dedicated DXC workforce composed of Claude-certified, forward-deployed engineers and builders who will be embedded in customer environments to accelerate agentic AI adoption.
The Anthropic announcement came the same morning DXC held its long-anticipated Investor Day in New York City. Company leadership, including President and CEO Raul Fernandez, presented the firm's strategy, long-term priorities, financial targets, and a slate of new AI-enabled solutions designed to advance DXC's transformation agenda.
Investors treated the combination of a headline AI partnership and a formal strategic roadmap as a clear commercial signal that DXC's move into AI is translating into tangible activity. DXC has already been using Claude within its own operations; the company reported that Claude served as the primary development tool for DXC OASIS. DXC estimated that use of Claude sped software delivery by roughly 10x, with more than 95% of code generated by Claude prior to human review.
The stock's pre-market surge contrasted with broader market weakness on the same day. The S&P 500, Dow Jones, and NASDAQ were all trading meaningfully lower, underscoring that DXC's rally appeared to be company-specific rather than driven by a general market upswing.
DXC's shares had been under pressure in recent months after the company's May 7 Q4/FY26 earnings release, which highlighted declines in revenue and provided guidance indicating an expected contraction in FY27 organic revenue. That earnings update prompted a steep pullback in the stock and led analysts to reduce their price targets. Following the earnings report, Morgan Stanley lowered its target to $9 and BMO Capital cut its target to $10.
Implications and context
- DXC's tie-up with Anthropic places the firm among a small group of premier partners authorized to deploy Claude at scale within enterprise environments.
- The company is operationalizing Claude not only in customer deployments but also internally as a development accelerant, citing significant gains in delivery speed for its DXC OASIS platform.
- The timing of the partnership announcement alongside Investor Day appears to have reinforced investor confidence in the company's strategic direction, producing an outsized share reaction relative to broader market performance.
What remains uncertain
- DXC recently disclosed revenue declines and guidance for FY27 organic revenue contraction, which contributed to prior share weakness - a factor that still represents performance risk.
- Analyst price targets were trimmed after the May earnings release, indicating continued skepticism among some market participants about near-term financial trajectory.
- The recent price jump is company-specific amid a broader market decline, so sustained outperformance will depend on execution against the newly announced partnership and the strategic priorities presented at Investor Day.